4-(3-ETHOXYPHENOXY)-3-METHYLANILINE
|
- $121 - $802.73
- Product name: 4-(3-ETHOXYPHENOXY)-3-METHYLANILINE
- CAS: 946698-89-1
- MF: C15H17NO2
- MW: 243.3
- EINECS:
- MDL Number:MFCD08687733
- Synonyms:4-(3-ETHOXYPHENOXY)-3-METHYLANILINE;Benzenamine, 4-(3-ethoxyphenoxy)-3-methyl-
4 prices
Selected condition：
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500mg
- 5g
- ManufacturerAK Scientific
- Product number4043AF
- Product description4-(3-Ethoxyphenoxy)-3-methylaniline
- Packaging500mg
- Price$213
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0033472
- Product description4-(3-ETHOXYPHENOXY)-3-METHYLANILINE 95.00%
- Packaging500MG
- Price$802.73
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12003491
- Product description4-(3-Ethoxyphenoxy)-3-methylaniline 97%
- Packaging5g
- Price$648
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number022718
- Product description4-(3-Ethoxyphenoxy)-3-methylaniline
- Packaging500mg
- Price$121
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 4043AF | 4-(3-Ethoxyphenoxy)-3-methylaniline | 500mg | $213 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CHM0033472 | 4-(3-ETHOXYPHENOXY)-3-METHYLANILINE 95.00% | 500MG | $802.73 | 2021-12-16 | Buy |
| Crysdot | CD12003491 | 4-(3-Ethoxyphenoxy)-3-methylaniline 97% | 5g | $648 | 2021-12-16 | Buy |
| Matrix Scientific | 022718 | 4-(3-Ethoxyphenoxy)-3-methylaniline | 500mg | $121 | 2021-12-16 | Buy |
Properties
Melting point :97-98°
Boiling point :376.0±32.0 °C(Predicted)
Density :1?+-.0.06 g/cm3(Predicted)
pka :4.88±0.10(Predicted)
Boiling point :376.0±32.0 °C(Predicted)
Density :1?+-.0.06 g/cm3(Predicted)
pka :4.88±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|